Literature DB >> 7690327

Collaboration of helper and cytotoxic T lymphocytes.

G Stuhler1, P Walden.   

Abstract

Cytotoxic T lymphocytes are major effector cells in response to viral infections and in allograft rejection and are implicated in many other immunological reactions. Efficient induction of cytotoxic activity in these cells in many but not all cases depends upon helper T and antigen-presenting cells so that at least three different cell types have to work together. Here we present an in vitro model for the helper T cell-dependent induction of cytotoxic T lymphocytes which allows the investigation of the collaboration of helper and cytotoxic T cells. First results demonstrate that linkage of helper and killer epitopes on the surface of one antigen-presenting cell is a prerequisite for productive interaction between the two T cells that results in induction of cytolytic activity. T helper 1 and T helper 2 cells are equally efficient. The crucial roles of interleukin-2 and interferon-gamma in this process were confirmed. Activated CD4 cells can influence cytotoxic T lymphocytes in such a way that they produce interferon-gamma independent from recognition of cognate peptide. The possibility of direct T-T contacts mediated by adhesion molecules that promote collaboration of the two cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690327     DOI: 10.1002/eji.1830230934

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.

Authors:  C D Partidos; P Vohra; M W Steward
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Recycled addition of CD4+ T cell-rich population for induction of human autologous cytotoxic T lymphocytes: A practically efficient method.

Authors:  K Saijo; H Tsurushima; K Tsuboi; T Nose; A Oki; T Ohno
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

4.  Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets.

Authors:  G Stuhler; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101.

Authors:  B Kitze; K Usuku; Y Yamano; S Yashiki; M Nakamura; T Fujiyoshi; S Izumo; M Osame; S Sonoda
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

6.  Modulation by gamma interferon of antiviral cell-mediated immune responses in vivo.

Authors:  O Utermöhlen; A Dangel; A Tárnok; F Lehmann-Grube
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  The influence of allo-class II MHC-specific Th2 cells on the generation of CD4 and CD8 cytotoxic T cells to associated class I and class II MHC alloantigen.

Authors:  P J Wood; I A Cossens
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

8.  Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.

Authors:  O Utermöhlen; C Schulze-Garg; G Warnecke; R Gugel; J Löhler; W Deppert
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.

Authors:  M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Bystander suppression of murine collagen-induced arthritis by long-term nasal administration of a self type II collagen peptide.

Authors:  S Bayrak; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.